Steris (STE) Net Income towards Common Stockholders (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -683.00% |
| Dec 31, 2024 | 50.00% |
| Sep 30, 2024 | -103.57% |
| Jun 30, 2024 | 103.63% |
| Mar 31, 2024 | -1,914.90% |
| Dec 31, 2023 | -72.05% |
| Sep 30, 2023 | 34.46% |
| Jun 30, 2023 | -242.52% |
| Mar 31, 2023 | 162.04% |
| Dec 31, 2022 | 98.25% |
| Sep 30, 2022 | -5,171.78% |
| Jun 30, 2022 | -108.90% |
| Mar 31, 2022 | -34.56% |
| Dec 31, 2021 | 105.52% |
| Sep 30, 2021 | 417.89% |
| Jun 30, 2021 | -117.48% |
| Mar 31, 2021 | 9.37% |
| Dec 31, 2020 | 8.09% |
| Sep 30, 2020 | 18.40% |
| Jun 30, 2020 | -18.94% |
| Mar 31, 2020 | -17.55% |
| Dec 31, 2019 | 40.79% |
| Sep 30, 2019 | 12.58% |
| Jun 30, 2019 | -15.96% |
| Mar 31, 2019 | 107.65% |
| Dec 31, 2018 | -37.51% |
| Sep 30, 2018 | 10.27% |
| Jun 30, 2018 | -74.99% |